Fairmount Funds Management LLC 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:48 pm Sale |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Fairmount Funds Management LLC | 0 0.000% |
-6,018,465 (Position Closed) |
Filing |
| 2023-02-14 3:45 pm Purchase |
2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Fairmount Funds Management LLC | 6,018,465 9.900% |
2,258,955 (+60.09%) |
Filing |
| 2022-04-21 10:00 am Purchase |
2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI |
Fairmount Funds Management LLC | 3,759,510 9.900% |
3,759,510 (New Position) |
Filing |